13F Holdings
中文EN

INGN Inogen Inc

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1294133 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.7%
TTM net income YoY-39.7%
TTM EPS YoY-32.0%
Revenue 3-yr CAGR5.0%
Net income 3-yr CAGR—

Margins

Gross margin39.6%
Operating margin-10.4%
Net margin-9.3%
FCF margin-3.0%
EBITDA margin-4.2%

Returns

ROE-20.0%
ROA-12.4%
ROIC (approx.)-37.5%
Asset turnover1.33x

Leverage & solvency

Liabilities / assets40.7%
Debt / equity0.00x
Current ratio2.96x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.26x
Accruals ratio-9.2%
Payout ratio—
Capex / revenue0.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$348.67M$335.70M$315.66M$377.24M$358.00M
Cost of revenue$194.40M$180.96M$188.96M$223.71M$181.52M
Gross profit$154.26M$154.74M$126.70M$153.53M$176.48M
R&D expense$19.40M$21.61M$20.84M$21.94M$16.58M
SG&A expense$67.38M$72.58M$75.26M$43.91M$37.85M
Operating income-$30.21M-$42.52M-$109.39M-$85.24M$9.24M
Pretax income-$23.38M-$36.48M-$102.34M-$83.27M$8.66M
Income tax-$632,000-$588,000$105,000$504,000$14.99M
Net income-$22.75M-$35.89M-$102.45M-$83.77M-$6.33M
EBITDA-$9.55M-$21.51M-$91.23M-$61.73M$30.87M
EPS (basic)-0.86-1.52-4.42-3.67-0.28
EPS (diluted)-0.86-1.52-4.42-3.67-0.28
Weighted avg. shares (diluted)26.60M23.65M23.18M22.85M22.49M
Balance sheet
Cash & equivalents$103.73M$113.80M$125.49M$187.01M$235.52M
Short-term investments$15.85M$0$2.98M—$9.99M
Receivables$34.14M$29.56M$42.24M$62.73M$24.45M
Inventory$25.97M$24.81M$21.84M$34.09M$31.87M
Current assets$224.60M$185.45M$207.07M$304.64M$329.19M
PP&E, net$10.06M$44.40M$50.32M$43.27M$38.93M
Goodwill$10.70M$9.46M$10.06M$32.85M$32.98M
Intangibles$30.76M$30.49M$34.59M$177,000$60.15M
Total assets$298.62M$296.19M$326.19M$405.04M$489.51M
Current liabilities$63.53M$76.69M$72.50M$65.35M$61.51M
Total liabilities$106.39M$122.33M$121.38M$107.64M$119.29M
Shareholders' equity$192.23M$173.86M$204.81M$297.41M$370.23M
Shares outstanding27.23M23.90M23.32M22.94M22.73M
Cash flow statement
Operating cash flow-$11.22M$5.91M-$3.23M-$37.53M$23.63M
Capital expenditure$2.52M$3.36M$5.22M$3.34M$5.48M
Free cash flow-$13.74M$2.55M-$8.45M-$40.87M$18.15M
Investing cash flow-$26.21M-$13.97M-$59.31M-$10.88M-$14.64M
Financing cash flow$24.18M$265,000$960,000$380,000$15.00M
Depreciation & amortization$20.66M$21.00M$18.15M$23.51M$21.63M
Stock-based compensation$8.01M$7.40M$7.43M$12.28M$10.94M

Free plan shows the latest 5 periods; Pro shows all 14 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.